论文部分内容阅读
目的观察依达拉奉注射液联合银杏达莫注射液治疗急性脑梗死的疗效。方法 186例急性脑梗死患者,随机分为对照组和观察组,各93例。对照组给予常规基础治疗,观察组在对照组的基础上,给予依达拉奉注射液联合银杏达莫注射液治疗。观察两组美国国立卫生院卒中量表(NIHSS)评分改善情况、临床疗效及不良反应。结果治疗后观察组的NIHSS评分改善优于对照组,差异具有统计学意义(P<0.05)。对照组总有效率为69.89%,观察组总有效率为90.32%,观察组总有效率明显优于对照组,差异具有统计学意义(P<0.05)。两组患者均未见明显不良反应。结论应用依达拉奉注射液联合银杏达莫注射液治疗急性脑梗死,可改善神经功能缺损,疗效好、安全性高,临床可推广应用。
Objective To observe the curative effect of edaravone injection and ginkgo dipyridamole injection on acute cerebral infarction. Methods 186 patients with acute cerebral infarction were randomly divided into control group and observation group, 93 cases in each. The control group was given routine basic treatment. The observation group was treated with edaravone injection combined with gingko Damo injection on the basis of the control group. The NIHSS scores, clinical efficacy and adverse reactions in the two groups were observed. Results After treatment, the NIHSS score of the observation group was better than that of the control group, with statistical significance (P <0.05). The total effective rate was 69.89% in the control group, and the total effective rate in the observation group was 90.32%. The total effective rate in the observation group was significantly better than that in the control group, with statistical significance (P <0.05). No significant adverse reactions in both groups of patients. Conclusion The application of edaravone injection combined with ginkgo dipyridamole injection in the treatment of acute cerebral infarction can improve neurological deficit, with good curative effect, high safety and clinical application.